|
ASTRAZENECA (: AZN)
|
|
|---|---|
| Pricing data not available | |
| Open: | $ n/a | Volume: | n/a | |
|---|---|---|---|---|
| High: | $ n/a | Yield(%) | n/a | |
| Low: | $ n/a | P/E Ratio (ttm): | n/a | |
| Dividend ($): | n/a | Market Cap ($): | n/a | |
| EPS ($) | n/a | Shares Out: | n/a |
| % Price Change (last 4 weeks): | -4.64 |
|---|---|
| % Price Change (last 13 weeks): | -14.70 |
| % Price Change (last 26 weeks): | -23.67 |
| % Price Change (last 52 weeks): | -2.22 |
| % Price Change (year to date): | -10.60 |
| Return on Equity (%): | 22.86 |
|---|---|
| Return on Assets (%): | 9.38 |
| Return on Invested Capital (%): | 8.01 |
| Gross Profit Margin (%): | 74.65 |
|---|---|
| Net Profit Margin (%): | 17.41 |
| Operating Profit Margin (%): | 23.85 |
|
|
|
| 50-day Moving Average: | $173.64 |
|---|---|
| 200-day Moving Average: | $184.31 |
| Avg. Daily Vol. (last 50 days): | 3,103,552 |
| Avg. Daily Vol. (last 200 days): | 2,669,643 |
| 52-wk high: | $n/a |
| 52-wk low: | $n/a |
| Bid: | $n/a |
| Ask: | $n/a |
|
AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.
|
|
ASTRAZENECA
Cambridge Biomedical Campus 1 Francis Crick Avenue Cambridge CA CB2 0AA Phone: 44.20.3749.5000 Fax: n/a http://www.astrazeneca.com |
| Earnings (1year) ($): | 6.74 |
|---|---|
| Annual Dividend ($): | 3.11 |
| Current P/E Ratio (ttm): | n/a |
| Book Value ($): | 31.38 |
| Cash Flow ($): | 10.13 |
| Price/Earnings (x): | 23.29 |
|---|---|
| Price/Sales (x): | 4.93 |
| Price/Book (x): | 5.91 |
| Price/Cash Flow (x): | 19.50 |
| Quick Ratio (x): | 0.72 |
|---|---|
| Current Ratio (x): | 0.94 |
| LT Debt/Equity (x): | 53.70 |
| Total Debt/Equity (x): | 60.87 |